Lilly Soars, China Stocks Stung, Nasdaq Climbs

🔔 After the Bell

🎯 Session Review

Monday delivered the kind of session where the headline number tells only half the story. The S&P 500 added 0.30% to close at 7,405.73 and the Nasdaq jumped 0.86% to 25,929.66, but the Dow slipped 0.16% to 50,786.01, reminding everyone that not all stocks got the memo about optimism today.

The split came down to who was winning and who was catching heat. Tech and pharma led the charge higher while industrials and travel-related names dragged on the blue-chip index. Treasury yields nudged up modestly, with the 10-year at 4.55% and the 30-year crossing 5.02%, keeping some pressure on rate-sensitive corners of the market.

Bitcoin held its ground near $63,352 and the Dollar Index barely moved at 100.03, so the macro backdrop was relatively quiet. The real action was in individual stocks, and there was plenty of it.

Gold's Best-Kept Secret: Monthly Income [ad]

📊 Today's Market Movers

▲ Gainers TNGX ▲ +52.97% GLXY ▲ +21.36% CBRS ▲ +18.32% MARA ▲ +11.85% OSCR ▲ +11.79%

▼ Losers BRC ▼ -15.04% AGX ▼ -10.8% TLK ▼ -9.49% FRVO ▼ -8.76% ENSG ▼ -8.15%

🚀 Key Catalysts

Eli Lilly (LLY) was the standout performer of the day, surging roughly 4% in premarket and holding gains after new clinical data on its next-generation obesity drug retatrutide showed promising results. Analysts say the data extends Lilly's already commanding lead in the GLP-1 space, and investors are pricing in a longer runway of dominance in a market that remains one of the hottest in all of healthcare.

Micron (MU) also caught a bid as an analyst highlighted how long-term supply contracts are reshoring earnings visibility for memory chipmakers, reviving enthusiasm for the memory trade. That helped lift the broader semiconductor complex and contributed to the Nasdaq's outperformance. Amazon (AMZN) and Corning (GLW) got attention after announcing a multibillion-dollar deal for optical fiber to power Amazon's expanding AI data center network, following similar megadeals Corning struck with Meta and Nvidia.

On the downside, Chinese tech names got bruised after the U.S. government released an updated military-linked entity list naming Alibaba (BABA), Baidu (BIDU), and BYD (BYDDF). That kind of designation creates real headaches around financing, partnerships, and investor appetite, and the market responded accordingly.

Inside SpaceX IPO Prospectus [ad]

15X Bigger Than SpaceX: Elon's New Launch

🎭 Investor Mood

The mood today felt like cautious optimism with a side of geopolitical anxiety. Investors were willing to chase good stories in pharma and tech, but the China military list news introduced a layer of tension that nobody was fully ready to shake off. When companies the size of Alibaba and Baidu show up on a U.S. government list, portfolio managers pay attention.

Airlines had a rough session on two fronts. Airline CEOs publicly blasted engine makers over delays and rising repair costs, warning the pain could stretch on for years. Then the International Air Transport Association piled on with a forecast that global airline profits will be cut in half in 2026 due to surging fuel costs, adding roughly 100 billion dollars to the industry's collective bill. The ETF JETS and names like AAL and DAL felt that pressure.

Red Sea shipping concerns added another layer of unease after Houthi forces threatened to bar Israel-linked vessels, rattling oil-related names like BNO, DBO, and GUSH. Energy markets are watching that situation closely.

Elon’s ‘iPhone’ Could 10x Apple’s iPhone [ad]

🔍 5 Focus Points for Tomorrow

📊	Watch LLY for follow-through analyst upgrades after the retatrutide obesity drug data drop

📊	Monitor BABA, BIDU, and BYDDF for institutional response to the U.S. military entity list

⛽	Track airline sector names AAL and DAL as fuel cost and engine delay warnings weigh on 2026 profit forecasts

🏛️	Keep an eye on the 30-year Treasury yield at 5.02% and whether it continues climbing toward new resistance

⛽	Watch Red Sea shipping developments and oil ETFs like BNO and GUSH as Houthi threats escalate

Trump Admin to Pump $1 Billion into this "Off-the-Radar" AI Stock

💸 Bottom Line

Heading into the rest of the week, the Lilly story is worth tracking closely. Retatrutide data this compelling tends to have legs, and we could see more analyst upgrades and price target revisions in the coming days as the research community digests the full results. The obesity drug race remains one of the most consequential competitive battles in pharma.

The China entity list development deserves a close watch too. BABA, BIDU, and BYDDF are widely held by institutional investors, and any escalation in U.S.-China tensions around this list could ripple beyond just those three names into the broader emerging markets trade. Keep an eye on how Washington follows up.

For the bond market, the 30-year yield sitting at 5.02% is a number that commands respect. If yields continue drifting higher, growth stocks that have been riding the AI wave could face renewed valuation pressure. The Nasdaq held up well today, but rates are the quiet variable that could change the calculus quickly. Stay sharp out there.

$1,000 into $556,454. Impossible? [ad]